Table 1.

Characteristics of cases with specimens submitted for diagnostic testing for MPX from North and South Kivu

Case	Province/health zone/village or town*	Gender, age (years)	Date of illness onset†	Date of specimen collection, type of specimen	OPXV/MPXV PCR‡	VZV PCR‡
1	North Kivu/Walikale/Boboro	Male, 28	November 22, 2011	November 23, vesicular swab and blood	Positive	N/A
2	North Kivu/Musienene/Butembo	Male, 24	September 1 or 2, 2012	September 12, crust and blood	Positive	N/A
3	North Kivu/Kayna/Kaleko	Female, 1.6	December 1, 2012	December 4, 2012, blood; December 8, 2012, vesicular swab and crust	Negative	Positive
4	South Kivu/Shabunda/Mabaka	Female, 23	December 8, 2012	December 17, blood	Positive	N/A
5	North Kivu/Butembo/Butembo	Male, 8	Unknown	July 19, blood	Negative	Negative
6	South Kivu/Minova/Bunge-Zicano	Male, 1.5	May 19, 2014	May 29, blood	Negative	Negative

MPXV = monkeypox virus; N/A = not applicable; OPXV = Orthopoxvirus, PCR = polymerase chain reaction; VZV = varicella zoster virus.

^*The locality information describes where the case lived at the time of illness onset.

^†Signs and symptoms present at the time of illness onset (i.e., fever, rash) are not precisely known.

^‡Suspect cases were reclassified as confirmed MPX cases if an original specimen tested positive for Orthopoxvirus (OPXV) DNA signatures at Institut National de Recherche Biomedicale (INRB)⁶ and/or if a specimen tested positive for MPXV DNA signatures at U.S. Centers for Disease Control and Prevention (CDC).⁷,⁸ Cases were classified as confirmed VZV cases if a specimen tested positive for VZV DNA signatures at INRB (reagents provided by the U.S. Army Medical Research Institute of Infectious Diseases, unpublished protocol).